Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Republic of Korea.
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Aging (Albany NY). 2021 Jul 8;13(13):16974-16989. doi: 10.18632/aging.203255.
We evaluated the association of metabolic health and obesity phenotypes with the risk of Alzheimer's disease (AD). This study enrolled 136,847 elderly participants aged 60 or above from the Korean National Health Insurance System. At baseline examinations in 2009 and 2010, subjects were categorized into four groups: the metabolically healthy non-obese (MHNO), metabolically healthy obese (MHO), metabolically unhealthy non-obese (MUNO), and metabolically unhealthy obese (MUO) groups. Based on the phenotypic transition after 2 years, the subjects were further categorized into 16 subgroups. They were followed from 2009 to 2015 to monitor for AD development. The MHO phenotype protected subjects from AD, relative to the MHNO phenotype (HR, 0.73; 95% CI, 0.65-0.81). Among subjects initially classified as MHO, 41.8% remained MHO, with a significantly lower risk of AD compared with the stable MHNO group (HR, 0.62; 95% CI, 0.50-0.77). Among MUO subjects at baseline, those who changed phenotype to MUNO were at higher risk of AD (HR, 1.47; 95% CI, 1.28-1.70), and the transition to the MHO phenotype protected subjects from AD (HR, 0.62; 95% CI, 0.50-0.78). The MHO phenotype conferred a decreased risk of AD. Maintenance or recovery of metabolic health might mitigate AD risk among obese individuals.
我们评估了代谢健康和肥胖表型与阿尔茨海默病(AD)风险的关联。本研究纳入了来自韩国国家健康保险系统的 136847 名 60 岁及以上的老年人。在 2009 年和 2010 年的基线检查中,受试者被分为四组:代谢健康非肥胖(MHNO)、代谢健康肥胖(MHO)、代谢不健康非肥胖(MUNO)和代谢不健康肥胖(MUO)组。根据两年后的表型转变,受试者进一步分为 16 个亚组。从 2009 年开始对他们进行随访,以监测 AD 的发展。与 MHNO 表型相比,MHO 表型可保护受试者免受 AD 的侵害(HR,0.73;95%CI,0.65-0.81)。在最初被归类为 MHO 的受试者中,有 41.8%仍然保持 MHO 表型,与稳定的 MHNO 组相比,AD 的风险显著降低(HR,0.62;95%CI,0.50-0.77)。在基线时为 MUO 的受试者中,那些表型转变为 MUNO 的受试者患 AD 的风险更高(HR,1.47;95%CI,1.28-1.70),而转变为 MHO 表型可保护受试者免受 AD 的侵害(HR,0.62;95%CI,0.50-0.78)。MHO 表型可降低 AD 的风险。维持或恢复代谢健康可能会降低肥胖人群患 AD 的风险。